Gilead Sciences - Foster City, CA
posted 4 months ago
Gilead Sciences, Inc. is a research-based biopharmaceutical company founded in 1987, dedicated to delivering life-saving therapies to patients in need. The Executive Director, Sterile Process Engineering and Packaging (SPEP), will play a strategic leadership role within the Drug Development and Commercial Product Engineering (DDCPE) organization. This role is pivotal in developing clinical and commercial devices, packaging, and fill/finish processes for combination products in Gilead's portfolio. The incumbent will be responsible for establishing global, end-to-end capabilities for the design, development, scale-up, and validation of processes for late-stage sterile drug product unit operations, including assembly and packaging for both small and large molecule parenteral drugs. The Executive Director will foster an environment of cross-functional collaboration, accountability, influence, and technical rigor, working closely with teams such as Formulation, Clinical Packaging, Device Engineering, Manufacturing Operations, and Supply Chain. This role requires a creative, open-minded, and highly motivated individual who is results-oriented and possesses high learning agility. The successful candidate will be an experienced people leader who develops, inspires, and empowers strong teams to achieve Gilead's mission of addressing unmet medical needs and improving life for patients with life-threatening diseases. Specific responsibilities include serving as a member of the DDCPE Leadership Team, providing technical and strategic leadership to sterile drug processes, leading a team to design and validate processes for sterile drug product unit operations, collaborating with various departments to ensure smooth transitions from development to commercialization, and driving the establishment of a state-of-the-art sterile process engineering lab. The Executive Director will also influence regulatory strategies, lead business process initiatives, champion sustainability initiatives, and develop staff capabilities in alignment with Gilead's growth strategies.